Siblings Conference Papers/Meeting Abstract [6/26] Patents [0/12] Collection Statistics Item counts issued in 3 years:4(5.71%) Items With Fulltext:70(100.00%) Download counts of the item Download times greater than 0:70(100.00%) Download times greater than 100:68(97.14%) Total Bitstream Download Counts:45556(91.96%) Last Update: 2025-04-20 03:10 Top Upload Loading... Top Download Loading... Recent Submissions Natural fucoidans inhibit coronavir... Vitamin B12 inhibits peptidylargini... Natural fucoidans inhibit coronavir... Guidelines for the use and interpre... The synergistic inhibition of coron... The synergistic inhibition of coron... Tyrphostin AG1024 suppresses corona... Remdesivir and cyclosporine synergi... Inhibition of SARS-CoV-2 by highly ... Natural cardenolides suppress coron...

Jump to a point in the index: (Choose year) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-10 of 70. (7 Page(s) Totally) 1 2 3 4 5 6 7 > >> View [10|25|50] records per page

Date	Title	Relation
2025-02	Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin[Erratum:Biochemical Pharmacology. 2023 Jul 20;215:Article number 115688.]	Biochemical Pharmacology. 2025 Feb;232:Article number 116753.
2024-02-15	Vitamin B12 inhibits peptidylarginine deiminases and ameliorates rheumatoid arthritis in CAIA mice	Biochemical and Biophysical Research Communications. 2024 Feb 15;704:Article number 149668.
2023-07-20	Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin	Biochemical Pharmacology. 2023 Jul 20;215:Article number 115688.
2023-01-19	The synergistic inhibition of coronavirus replication and induced cytokine production by ciclesonide and the tylophorine-based compound dbq33b [Erratum:Pharmaceutics. 2022 Jul 21;14(7):Article number 1511.]	Pharmaceutics. 2023 Jan 19;15(2):Article number 342.
2022-07-21	The synergistic inhibition of coronavirus replication and induced cytokine production by ciclesonide and the tylophorine-based compound dbq33b	Pharmaceutics. 2022 Jul 21;14(7):Article number 1511.
2022-02-17	Tyrphostin AG1024 suppresses coronaviral replication by downregulating JAK1 via an IR/IGF-1R independent proteolysis mediated by Ndfip1/2_NEDD4-like E3 ligase itch	Pharmaceuticals. 2022 Feb 17;15(2):Article number 241.
2021-08-13	Remdesivir and cyclosporine synergistically inhibit the human coronaviruses OC43 and SARS-CoV-2	Frontiers in Pharmacology. 2021 Aug 13;12:Article number 706901.
2020-12-14	Inhibition of SARS-CoV-2 by highly potent broad-spectrum anti-coronaviral tylophorine-based derivatives	Frontiers in Pharmacology. 2020 Dec 14;11:Article number 606097.
2020-12	Natural cardenolides suppress coronaviral replication by downregulating JAK1 via a Na(+)/K(+)-ATPase independent proteolysis[Erratum:Biochemical Pharmacology. 2020 Oct;180:Article number 114122.]	Biochemical Pharmacology. 2020 Dec;182:Article number 114287.
2020-10	Natural cardenolides suppress coronaviral replication by downregulating JAK1 via a Na(+)/K(+)-ATPase independent proteolysis	Biochemical Pharmacology. 2020 Oct;180:Article number 114122.

Showing items 1-10 of 70. (7 Page(s) Totally) 1 2 3 4 5 6 7 > >> View [10|25|50] records per page